Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area apoptosis bax'

Search results for: 'research area apoptosis bax'

Items 31-40 of 72

Page
per page
  1. PHA-767491
    A3721 PHA-767491
    Target: Cyclin-Dependent Kinases|MK2|Cdc7
    Summary: Cdc7/cdk9 inhibitor, potent, ATP-competitive
      insoluble in H2O; insoluble in EtOH; ≥10.65 mg/mL
  2. SU5416
    A3847 SU5416
    Target: VEGFR
    Summary: VEGF receptor inhibitor and AHR agonist
      insoluble in EtOH; insoluble in H2O; ≥11.9 mg/mL
  3. Celastrol
    A2604 Celastrol
    Target: Proteasome
    Summary: Antioxidant, anti-inflammatory and immunosuppressive agent
      ≥22.55 mg/mL
  4. Lenalidomide (CC-5013)
    A4211 Lenalidomide (CC-5013)
    Target: angiogenesis
    Summary: Antineoplastic agent,inhibits angiogenesis
      insoluble in EtOH; insoluble in H2O; ≥100.8 mg/mL
  5. Pomalidomide (CC-4047)
    A4212 Pomalidomide (CC-4047)
    Summary: Immunomodulator,antumor/anti-angiogenic
      insoluble in EtOH; insoluble in H2O; ≥7.5 mg/mL
  6. Necrostatin-1
    A4213 Necrostatin-1
     5 Citation
    Target: RIP kinases
    Summary: RIP1 inhibitor
      insoluble in H2O; ≥12.97 mg/mL
  7. Mitomycin C
    A4452 Mitomycin C
     3 Citation
    Summary: Inhibits DNA synthesis,antibiotic and antitumor agent
      insoluble in H2O; insoluble in EtOH; ≥16.7 mg/mL
  8. CID 755673
    A8678 CID 755673
    Target: PKD
    Summary: PKD inhibitor
  9. ABT-199
    A8194 ABT-199
     14 Citation
    Target: Bcl-2
    Summary: Bcl-2 inhibitor,potent and selective
      ≥43.42 mg/mL
  10. ABT-263 (Navitoclax)
    A3007 ABT-263 (Navitoclax)
     15 Citation
    Target: Bcl-2|Bcl-w
    Summary: Potent Bcl-2 family inhibitor, inhibits Bcl-2, Bcl-xL, and Bcl-w
      ≥48.73 mg/mL

Items 31-40 of 72

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 69item
  2. Natural Products 4item
  3. Lab Reagents 1 item
Specificity
  1. Selective 43item
Reversibility
  1. Irreversible 4item
Target
  1. Caspases 6item
  2. Cyclin-Dependent Kinases 1 item
  3. Proteasome 1 item
  4. Histone Deacetylases (HDACs) 4item
  5. Inhibitor of apoptosis proteins (IAP) 2item
  6. Bcl-2 5item
  7. Raf 2item
  8. Aurora Kinases 1 item
  9. Bcl-xl 1 item
  10. MDM2 2item
  11. AP-1 1 item
  12. DT-diaphorases 1 item
  13. GSK-3 1 item
  14. VEGFR 3item
  15. PDGFR 2item
  16. c-Kit 2item
  17. RET 1 item
  18. Mcl-1 1 item
  19. Thymidylate Synthase 1 item
  20. Nrf2 1 item
  21. Sir2-like Family Deacetylases (Sirtuins) 1 item
  22. Deubiquitinating enzymes (DUBs) 1 item
  23. Aminopeptidases 1 item
  24. STAT 1 item
  25. Estrogen and Related Receptors 1 item
  26. RIP kinases 1 item
  27. Hypoxia Inducible Factors (HIFs) 1 item
  28. JAK 3item
  29. HSP90 1 item
  30. Topoisomerases 1 item
  31. Cytochrome P450 (CYP450) 1 item
  32. Survivin 1 item
  33. Ubiquitin-specific proteases 1 item
  34. Melanocortin (MC) Receptors 1 item
  35. MK2 1 item
  36. Fatty-acid-binding proteins (FABPs) 1 item
  37. Autophagy 1 item
  38. NADPH Oxidases 1 item
  39. MAGL 1 item
  40. Histamine H1 Receptors 1 item
  41. TRP Channel 1 item
  42. Glucocorticoid Receptors 1 item
  43. Cdc7 1 item
  44. angiogenesis 1 item
  45. c-RET 1 item
  46. FPTase 1 item
  47. p53 4item
  48. cysteine protease 1 item
  49. HDM2 ubiquitin ligase 1 item
  50. PC-PLC 1 item
  51. Glucosidases 1 item
  52. HIV 1 item
  53. Histone Acetyltransferases (HATs) 1 item
  54. Telomerases 1 item
  55. Tyrosinases 1 item
  56. HSP70 1 item
  57. phosphatidylinositol kinase 1 item
  58. Adenosine Deaminases 1 item
  59. p21 1 item
  60. DHFR 1 item
  61. GARFT 1 item
  62. RHA 1 item
  63. TRPC channel 1 item
  64. PKD 1 item
  65. Bcl-w 1 item
  66. Bax 1 item
  67. NS3/4a Proteases 1 item
Related Disease
  1. Autoimmune Diseases 1 item
  2. Breast Cancer 10item
  3. Cancer 41item
  4. Chronic Lymphocytic Leukemia 1 item
  5. Chronic Myeloproliferative Disorders 1 item
  6. Colon Cancer 3item
  7. Colon Carcinoma 1 item
  8. Colorectal Cancer 3item
  9. Glioblastoma 4item
  10. HCV 1 item
  11. Hepatocellular Carcinoma 1 item
  12. Inflammatory Diseases 2item
  13. Leukemia 1 item
  14. Lung Cancer 1 item
  15. Lymphoma 3item
  16. Melanoma 4item
  17. Multiple Myeloma 1 item
  18. Myelofibrosis 1 item
  19. Myeloma 1 item
  20. Neuroblastoma 1 item
  21. Non-small Cell Lung Cancer 2item
  22. Ovarian Cancer 1 item
  23. Pain Relief 1 item
  24. Pancreatic Cancer 3item
  25. Pentacyclic Triterpenoid 1 item
  26. Prostate Cancer 7item
  27. Pulmonary Fibrosis 1 item
  28. Rheumatoid Arthritis 2item
  29. Soft Tissue Sarcoma 1 item
  30. Testicular Cancer 1 item
  31. Type 2 Diabetes 2item